In December’s issue of Spinco Biotech’s Cutting Edge magazine, SOPAT’s founder and CEO Dr. Sebastian Maaß talks about the importance of particle size analysis in the pharmaceutical industry.

In the five-page article, the importance of the particle size is highlighted as an important attribute in APIs, solid oral drug products (tablets and capsules – impacting on homogeneity, flow and processing), and as a critical quality attribute in semi-solids (suspensions) and sterile liquid products (injectables).

The full article can be downloaded here.